Elevating serum FGF21 levels through exogenous administration or liver overexpression induces weight loss, enhances energy expenditure, improves glucose metabolism and insulin sensitivity, alleviates hepatic steatosis, promotes lipolysis, induces browning of WAT, and activates BAT function [15–21]. Here, FGF21 is linked to fatty liver disease.